Frontiers in Psychiatry | Psychopharmacology

Case Report

Accepted on 04 Sep 2025

A case report of seizure worsening after perampanel add-on to oxcarbazepine: possible role of metabolic interaction and pharmacogenetics

in Psychopharmacology

Xin Fang
Menglu Zhu
Lijiang Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1621598

Correction

Accepted on 04 Sep 2025

Therapeutic and Legal Aspects of Psilocybin in Cancer-Related Depression

in Psychopharmacology

Małgorzata Wierzbicka
Renata Kopczyk
Aleksandra Gerlach
Joanna Rymaszewska

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1698185

Original Research

Accepted on 02 Sep 2025

Arrhythmic events pertinent with antidepressants: A Bayesian disproportional analysis mining the FDA Adverse Event Reporting System (FAERS) database

in Psychopharmacology

姗曹
Zhuoshan Huang
Wenjie Yang
Saijia Yang
Xi Chen
Xiaoxian Qian
Xujing Xie

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1637471

140 views

Clinical Trial

Published on 02 Sep 2025

Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial

in Psychopharmacology

Mina Kheirkhah
Nastasia McDonald
Julia Aepfelbacher
Manivel L. Rengasamy
Sharvari Shivanekar
Crystal Spotts
Iya Cooper
Andrew Baumeister
Elizabeth Bell
Kevin Do-Nguyen

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1642025

761 views

Perspective

Accepted on 01 Sep 2025

The Collective Lie in Ketamine Therapy: A Call to Realign Clinical Practice with Neurobiology

in Psychopharmacology

Charles Brian Miller
Bryan Lopes
Anna McCurdy

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1610335

330 views

Systematic Review

Accepted on 01 Sep 2025

Reporting of harms in systematic reviews focused on naltrexone: a cross-sectional study

in Psychopharmacology

Joseph Schnitker
Lindsey Purcell
Morgan Garrett
Holly Flores
Audrey Wise
Micah Kee
Brayden Rucker
Adam Khan
Jason Beaman
Matt Vassar

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1597019

309 views

Perspective

Published on 01 Sep 2025

Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes

in Psychopharmacology

Ronit Kishon
Yael M. Cycowicz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1637162

642 views

Review

Published on 01 Sep 2025

Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices

in Psychopharmacology

Amie R. Throneberry
Bradley G. Burk
Brandon S. Pruett

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1659290

612 views

Case Report

Published on 28 Aug 2025

Case Report: Clinical pharmacist prescriber in depression treatment in primary care settings: clinical case focused on prescribing practice

in Psychopharmacology

Matej Stuhec

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1677152

717 views

Original Research

Published on 28 Aug 2025

Pharmacist-assisted implementation of guideline recommendations for QTc monitoring during psychopharmacotherapy - a prospective, randomized feasibility study

in Psychopharmacology

Katharina Wien
Jan Philipp Klein
Niels Rodenstein
Julia Vogler
Roland Richard Tilz
Julia Thern
Stefan Borgwardt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1606497

692 views

Original Research

Accepted on 26 Aug 2025

Medication Adherence in Obsessive-Compulsive Disorders and Evaluation of Effective Adherence Support Strategies

in Psychopharmacology

Sophia Pöppel
Sina Ziegler
Klara Bednasch
Elisabeth Kohls
Christine Rummel-Kluge

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1642622

479 views

Opinion

Published on 26 Aug 2025

Psychedelic minimalism: the case against music in psychedelic therapy settings

in Psychopharmacology

Samir A Nader

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1652568

1,343 views

Original Research

Accepted on 25 Aug 2025

Changes in self-reported alcohol consumption at high and low consumption in the wake of the COVID-19 pandemic: A test of the polarization hypothesis

in Psychopharmacology

Alexander Tran
Huan Jiang
Shannon Lange
Mindaugas Štelemėkas
Daumantas Stumbrys
Ilona Tamutienė
Jürgen Rehm

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1516090

234 views

Hypothesis and Theory

Accepted on 18 Aug 2025

A Framework for Safe Estradiol Modulation in Male Bipolar Disorder: Theoretical Justification for SERM-Enabled Adjunctive Therapy

in Psychopharmacology

John Carlson

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1644175

377 views

Original Research

Published on 15 Aug 2025

Post marketing safety assessment of the novel postpartum depression drug, Zuranolone: evidence from real-world pharmacovigilance analysis based on the FDA adverse event reporting system

in Psychopharmacology

Duoqin Huang
Zixin Luo
Xi Gong
Kang Zou
Yu Peng
Shaoying Zeng

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1517773

1,312 views

Original Research

Published on 08 Aug 2025

Better treatment outcomes with aripiprazole long-acting injection in community and incarcerated patients with serious mental illness

in Psychopharmacology

Erasmia I. Koiliari
Ioannis Mouzas
Georgios Alevizopoulos
Otto Lesch
Henriette Walter
Emmanouil L. Pasparakis

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1499400

1,274 views